Enfamil Infant Formula
Allegations: Failing to disclose that products contain toxic heavy metals
Several Enfamil Formulas
Case Name (Date)
Hawes et al. v. Mead Johnson & Co., LLC and Reckitt Benckiser, LLC
24-cv-2930, N.D. Cal.
(May 2024)
Product/Service
Enfamil NeuroPro Infant Formula, Enfamil Simply ProSobee Plant-Based Infant Formula, and Enfamil Infant Formula Milk-based Powder with Iron
Allegations
Falsely marketing products as safe, healthy, nutritious, and committed to reducing their environmental impact when they contain harmful chemicals, including organic fluorine, perfluoroalkyl and polyfluoroalkyl substances (PFAS)
Status
Pending
Class-Action Tracker
Enfamil Infant Formulas
Allegations: Misleadingly marketing infant formulas as “Milk-based” when the primary ingredient is a form of sugar
Enfamil Baby Formula Powders
Allegations: Products do not contain enough powder to make the advertised number of bottles
Enfagrow Premium Toddler Transitions
In November 2020, a class-action lawsuit was filed against Mead Johnson & Company for, among other things, allegedly deceptively marketing Enfagrow Premium Toddler Transitions formula as “nutritionally appropriate” for children…
The Latest
CATrends: OTC Cold and Flu Meds Falsely Marketed as Nasal Decongestants
An FDA panel’s recent findings has led to a flood of lawsuits.
Researchers Call on FDA (Again) to Remove ‘Ineffective’ OTC Cold and Flu Medicines
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva
TINA.org files brief urging court to deny final approval of settlement that is unfair to consumers.
CATrends: Toddler Formula
It’s the perfect formula for a class-action lawsuit trend.
